Guest Posting

If you wish to write and/or publish an article on Operation Disclosure all you need to do is send your entry to UniversalOm432Hz@gmail.com applying these following rules.


The subject of your email entry should be: "Entry Post | (Title of your post) | Operation Disclosure"

- Must be in text format
- Proper Grammar
- No foul language
- Your signature/name/username at the top

Send your entry and speak out today!

News Alerts

RV/INTELLIGENCE ALERT - November 20, 2017


- EVERYTHING IS SET.


- NOTHING HAS CHANGED.


- THERE ARE NO DELAYS.


- ALL INDICTMENTS ARE READY TO BE UNSEALED.


- THE CABAL HAVE LOST.


- THE TRIGGER WAS PULLED, THE RELEASE HAD ALREADY BEGUN.


- THE RELEASE IS A PROCESS THAT COULD TAKE HOURS, OR DAYS TO REACH 100% COMPLETION.


- IT'S ONLY A MATTER OF TIME UNTIL THE PROCESS REACHES THE COURIERS TO GIVE THE GO-AHEAD TO DISTRIBUTE THE 800#'s.


- KEEP AND EYE OUT FOR THE 800#'s.


---


FOR MORE INFORMATION ABOUT THE RV/GCR VISIT:


http://www.dinarchronicles.com/intel.html


---

Featured Post

Restored Republic via a GCR as of Nov. 21, 2017

Restored Republic via a GCR Update as of Nov. 21 2017 Compiled 12:05 am EDT 21 Nov. 2017 by Judy Byington, MSW, LCSW, ret, CEO, Child Abus...

Wednesday, April 13, 2016

Marijuana Cures Alzheimer's and Parkinson's Disease

April 9, 2016 eClinik

The United States government has a patent on cannabinoids as anti-oxidant for auto-immune diseases, and as neuroprotectants for treatment of Alzheimer’s disease, Parkinson’s disease, and HIV dementia.

Ironically, government policies are not in sync with realities on the ground and with its own scientific discoveries. This only proves that government is indeed not in control of itself.

From US Patent 6630507 B1’s abstract,

“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.”


Receive News from Operation Disclosure via Email

Shoutbox Disclaimer

Please be advised that the Shoutbox is NOT moderated. Use it at your own will.